FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks
Science Advances · 02.06.2023 · 9 (22)
DOI: 10.1126/sciadv.adf4409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 02.06.2023. Verfasst von Abdelghani Mazouzi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands. Hauptthemen laut MEDLINE: DNA Damage, DNA Repair. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
DNA interstrand crosslinks (ICLs) pose a major obstacle for DNA replication and transcription if left unrepaired. The cellular response to ICLs requires the coordination of various DNA repair mechanisms. Homologous recombination (HR) intermediates generated in response to ICLs, require efficient and timely conversion by structure-selective endonucleases. Our knowledge on the precise coordination of this process remains incomplete. Here, we designed complementary genetic screens to map the machinery involved in the response to ICLs and identified FIRRM/C1orf112 as an indispensable factor in maintaining genome stability. FIRRM deficiency leads to hypersensitivity to ICL-inducing compounds, accumulation of DNA damage during S-G 2 phase of the cell cycle, and chromosomal aberrations, and elicits a unique mutational signature previously observed in HR-deficient tumors. In addition, FIRRM is recruited to ICLs, controls MUS81 chromatin loading, and thereby affects resolution of HR intermediates. FIRRM deficiency in mice causes early embryonic lethality and accelerates tumor formation. Thus, FIRRM plays a critical role in the response to ICLs encountered during DNA replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands.
- Oncode Institute, Amsterdam, Netherlands.
- Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands.
- Somatic Evolution, Wellcome Sanger Institute, Hinxton, UK.
- Division of Cell Biology, Netherlands Cancer Institute, Amsterdam, Netherlands.
- BioImaging Facility, Netherlands Cancer Institute, Amsterdam, Netherlands.
ORCID-Profile: Abdelghani Mazouzi, Sarah C Moser, Federico Abascal, Bram van den Broek, Martin Del Castillo Velasco-Herrera, Ingrid van der Heijden, Maarten Hekkelman, Kees Jalink, David J Adams, Jos Jonkers, Thijn R Brummelkamp
Förderung
- Wellcome Trust
Zitieren
APA
Mazouzi, A., Moser, S. C., Abascal, F., van den Broek, B., Del Castillo Velasco-Herrera, M., van der Heijden, I., Hekkelman, M., Drenth, A. P., van der Burg, E., Kroese, L. J., Jalink, K., Adams, D. J., Jonkers, J., & Brummelkamp, T. R. (2023). FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks. Science Advances, 9(22). https://doi.org/10.1126/sciadv.adf4409
Vancouver
Mazouzi A, Moser SC, Abascal F, van den Broek B, Del Castillo Velasco-Herrera M, van der Heijden I, et al. FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks. Science Advances. 2023;9(22). doi:10.1126/sciadv.adf4409
BibTeX
@article{Mazouzi2023,
author = {Mazouzi, Abdelghani and Moser, Sarah C and Abascal, Federico and van den Broek, Bram and Del Castillo Velasco-Herrera, Martin and van der Heijden, Ingrid and Hekkelman, Maarten and Drenth, Anne Paulien and van der Burg, Eline and Kroese, Lona J and Jalink, Kees and Adams, David J and Jonkers, Jos and Brummelkamp, Thijn R},
title = {FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {22},
doi = {10.1126/sciadv.adf4409}
}
EUVIMED